Items where Subject is "C540 Virology"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Keywords | Item Type
Jump to: B | C | F | G | I | M | O | P | S | Z
Number of items at this level: 27.

B

Biswas, S., Sanyal, A., Hemadri, D., Tosh, C., Gupta, S. K., Mittal, M., Mohapatra, J. K., Sabarinath, G. P., Kumar, R. Manoj and Bandyopadhyay, S. K. (2004) Sequence analysis of Vpg protein of Asia-1 field isolates of Foot and Mouth Disease Virus in India. Journal of Animal and Veterinary Advances, 3 (8). pp. 522-526. ISSN 1680-5593

Biswas, S., Sanyal, A., Hemadri, D., Tosh, C., Mohapatra, J. K., Kumar, R. Manoj and Bandyopadhyay, S. K. (2005) Genetic comparison of large fragment of the 5'untranslated region among foot-and-mouth disease viruses with special reference to serotype Asia1. Archives of Virology, 150 (11). pp. 2217-2239. ISSN 0304-8608

Biswas, Subhajit, Candotti, Daniel and Allain, Jean-Pierre (2013) Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. Journal of Virology, 87 (14). pp. 7882-7892. ISSN 0022-538X

Biswas, Subhajit and Field, Hugh J. (2011) Helicase–primase inhibitors: a new approach to combat herpes simplex virus and varicella zoster virus. In: Antiviral Drug Strategies. Methods and Principles in Medicinal Chemistry . Wiley-VCH Verlag GmbH & Co. KGaA, pp. 129-146. ISBN 9783527635955, 9783527326969

Biswas, Subhajit and Field, Hugh J. (2008) Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations. Antiviral Chemistry & Chemotherapy, 19 (1). pp. 1-6. ISSN 0956-3202

Biswas, Subhajit, Jennens, Lyn and Field, Hugh J. (2007) Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture. Archives of Virology, 152 (8). pp. 1489-1500. ISSN 0304-8608

Biswas, Subhajit, Jennens, Lyn and Field, Hugh J. (2007) The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1. Antiviral Research, 75 (1). pp. 30-35. ISSN 0166-3542

Biswas, Subhajit, Kleymann, Gerald, Swift, Mihaiela, Tiley, Laurence S., Lyall, Jonathan, Aguirre-Hernández, Jesús and Field, Hugh J. (2008) A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target. Journal of Antimicrobial Chemotherapy, 61 (5). pp. 1044-1047. ISSN 0305-7453

Biswas, Subhajit, Li, Wilson, Manktelow, Emily, Lever, Jonathan, Easton, Laura E., Lukavsky, Peter J., Desselberger, Ulrich and Lever, Andrew M. (2014) Physicochemical analysis of rotavirus segment 11 supports a 'modified panhandle' structure and not the predicted alternative tRNA-like structure (TRLS). Archives of Virology, 159 (2). pp. 235-248. ISSN 0304-8608

Biswas, Subhajit, Nunez Miguel, Ricardo, Sukla, Soumi and Field, Hugh J. (2009) A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure. Journal of General Virology, 90 (8). pp. 1937-1942. ISSN 0022-1317

Biswas, Subhajit, Smith, Christopher and Field, Hugh J. (2007) Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1. The Journal of Antimicrobial Chemotherapy, 60 (2). pp. 274-279. ISSN 0305-7453

Biswas, Subhajit, Sukla, Soumi and Field, Hugh J. (2014) Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections. Future Medicinal Chemistry, 6 (1). pp. 45-55. ISSN 1756-8919

Biswas, Subhajit, Swift, Mihaiela and Field, Hugh J. (2007) High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1. Antiviral Chemistry & Chemotherapy, 18 (1). pp. 13-23. ISSN 0956-3202

Biswas, Subhajit, Tiley, Laurence S., Zimmermann, Holger, Birkmann, Alexander and Field, Hugh J. (2008) Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity. Antiviral Research, 80 (1). pp. 81-85. ISSN 0166-3542

C

Candotti, Daniel, Lin, C. Kit, Belkhiri, Dalila, Sakuldamrongpanich, Tasanee, Biswas, Subhajit, Lin, Sujen, Teo, Diana, Ayob, Yasmin and Allain, Jean-Pierre (2012) Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut, 61 (12). pp. 1744-1753. ISSN 0017-5749

F

Field, Hugh J. and Biswas, Subhajit (2011) Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus. Drug Resistance Updates, 14 (1). pp. 45-51. ISSN 1368-7646

Field, Hugh J., Biswas, Subhajit and Mohammad, Islam T. (2006) Herpesvirus latency and therapy--from a veterinary perspective. Antiviral Research, 71 (2-3). pp. 127-133. ISSN 0166-3542

G

Goncheva, Mariya I., Conceicao, Carina, Tuffs, Stephen W., Lee, Hui-Min, Quigg-Nicol, Marlynne, Bennet, Ian, Sargison, Fiona, Pickering, Amy C., Hussain, Saira, Gill, Andrew C., Dutia, Bernadette M., Digard, Paul, Fitzgerald, J. Ross and Palese, Peter (2020) Staphylococcus aureus Lipase 1 Enhances Influenza A Virus Replication. mBio, 11 (4). ISSN 2150-7511

Graham, Ciaren, Matta, Hittu, Yang, Yanqiang, Yi, Han, Suo, Yulan, Tolani, Bhairavi and Chaudhary, Preet M. (2013) Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor induced growth arrest and apoptosis through NF-κB activation. Journal of Virology, 87 (4). pp. 2242-2252. ISSN 0022-538x

I

Igwe, Paul Agu (2020) Coronavirus with Looming Global Health and Economic Doom. African Development Institute of Research Methodology .

M

Matta, M., Gopalakrishnan, R., Graham, Ciaren, Tolani, B., Khanna, A., Yi, H., Suo, Y. and Chaudhary, P. M. (2012) Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC. PloS One, 7 (5). e36601. ISSN 1932-6203

Mohapatra, Jajati K., Sanyal, Aniket, Hemadri, Divakar, Tosh, Chakradhar, Biswas, Subhajit, Knowles, Nick J., Rasool, Thaha J., Bandyopadhyay, Santanu K. and Pattnaik, Bramhadev (2008) Comparative genomics of serotype Asia 1 foot-and-mouth disease virus isolates from India sampled over the last two decades. Virus Research, 136 (1-2). pp. 16-29. ISSN 0168-1702

O

Onarinde, Bukola and Dixon, Ron (2018) Prospects for biocontrol of Vibrio parahaemolyticus contamination in blue mussels (Mytilus edulus) – a year-long study. Frontiers in Microbiology, 9 (1043). ISSN 1664-302X

P

Pereira, Carina F, Wise, Helen M., Kurian, Dominic, Pinto, Rute M., Amorim, Maria J, Gill, Andrew and Digard, Paul (2018) Pleiotropic effects of mutations in the effector domain of influenza A virus NS1 protein. BMC Research Notes, 11 (673). ISSN 1756-0500

S

Sukla, Soumi, Biswas, Subhajit, Birkmann, Alexander, Lischka, Peter, Zimmermann, Holger and Field, Hugh J. (2010) Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor. Journal of Antimicrobial Chemotherapy, 65 (7). pp. 1347-1352. ISSN 0305-7453

Sukla, Soumi, Biswas, Subhajit, Birkmann, Alexander, Lischka, Peter, Ruebsamen-Schaeff, Helga, Zimmermann, Holger and Field, Hugh J. (2010) Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant. Antiviral Research, 87 (1). pp. 67-73. ISSN 0166-3542

Z

Zumla, Alimuddin, Ippolito, Giuseppe, McCloskey, Brian, Bates, Matthew, Ansumana, Rashid, Heymann, David, Kock, Richard and Ntoumi, Francine (2017) Enhancing preparedness for tackling new epidemic threats. Lancet Respiratory Medicine, 5 (8). pp. 606-608. ISSN 2213-2600

This list was generated on Tue Sep 22 17:49:01 2020 BST.